Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | C21orf33 |
| Upstream (Parents) |
|---|
| (<<) ETFDH → C21orf33 |
| (<<) NNT → C21orf33 |
| Downstream (Children) |
|---|
| C21orf33 → SEMA3C (>>) |
| C21orf33 → DHRS2 (>>) |
| C21orf33 → HNF4A (>>) |
| C21orf33 → CXCR1 (>>) |
| C21orf33 → ICAM4 (>>) |
| C21orf33 → CDC42EP4 (>>) |
| C21orf33 → GALK1 (>>) |
| C21orf33 → MR1 (>>) |
| C21orf33 → KCNB1 (>>) |
| C21orf33 → INSR (>>) |
| C21orf33 → CAPG (>>) |
| C21orf33 → MVK (>>) |
| C21orf33 → EIF4EBP2 (>>) |
| C21orf33 → SC5DL (>>) |
| C21orf33 → PAIP2B (>>) |
| C21orf33 → PDE3B (>>) |
| C21orf33 → ALDH1B1 (>>) |
